A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up-Reference-Cited by-同舟云学术

A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up

Published:2012-03-19 Issue:11 Volume:47 Page:1448-1454
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Kasow K A,Stewart C F,Barfield R C,Wright N L,Li C,Srivastava D K,Leung W,Horwitz E M,Bowman L C,Handgretinger R,Hale G A

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201251.pdf

Reference46 articles.

1. Shih CS, Hale GA, Gronewold L, Tong X, Laningham FH, Gilger EA et al. High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors. Cancer 2008; 112: 1345–1353.

2. Hale GA . Autologous hematopoietic stem cell transplantation for pediatric solid tumors. Expert Rev Anticancer Ther 2005; 5: 835–846.

3. London WB, Frantz CN, Campbell LA, Seeger RC, Brumback BA, Cohn SL et al. Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study. J Clin Oncol 2010; 28: 3808–3815.

4. Zage PE, Kletzel M, Marcus R, Castleberry R, Zhang Y, London WB et al. Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 2008; 51: 747–753.

5. Carol H, Houghton PJ, Morton CL, Kolb EA, Gorlick R, Reynolds CP et al. Initial testing of topotecan by the pediatric preclinical testing program. Pediatr Blood Cancer 2010; 54: 707–715.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Giant Pediatric Supratentorial Tumor: Clinical Feature and Surgical Strategy;Frontiers in Pediatrics;2022-04-26

2. Topotecan induces hepatocellular injury via ASCT2 mediated oxidative stress;Gastroenterología y Hepatología;2021-01

3. Topotecan induces hepatocellular injury via ASCT2 mediated oxidative stress;Gastroenterología y Hepatología (English Edition);2021-01

4. Prognostic and therapeutic factors influencing the clinical outcome of hepatoblastoma after liver transplantation: A single-institute experience;Pediatric Transplantation;2018-01-17

5. Triggering of Suicidal Erythrocyte Death by Topotecan;Cellular Physiology and Biochemistry;2015